Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Management of fibromyalgia, a distinct rheumatologic syndrome
D. R. Miller,
R. D. Seifert
Administration (CoP)
Research output
:
Contribution to journal
›
Review article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Management of fibromyalgia, a distinct rheumatologic syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemical Compounds
Cyclobenzaprine
100%
Musculoskeletal
42%
Myorelaxant Agent
40%
Amitriptyline
37%
Anti-Inflammatory Drug
33%
Phenothiazine
30%
Neurotransmitter
29%
Fibrous Crystal
26%
Dose
20%
Drug
13%
Medicine & Life Sciences
Fibromyalgia
62%
cyclobenzaprine
31%
Tricyclic Antidepressive Agents
20%
Sleep
13%
Phenothiazines
12%
Amitriptyline
11%
Musculoskeletal Pain
10%
Rheumatologists
10%
Pain Perception
10%
Pain
10%
Non-Steroidal Anti-Inflammatory Agents
9%
Pharmacists
8%
Osteoarthritis
7%
Neurotransmitter Agents
7%
Rheumatoid Arthritis
7%
Psychology
5%
Exercise
5%
Education
5%
Muscles
5%
Inflammation
5%
Drug Therapy
5%
Therapeutics
4%
Incidence
4%